MedicarePartD.guide

A non-government resource built from CMS public data

Emgality on Blue Cross MedicareRx Value (S5715-020)

galcanezumab

Covered, with prior authorization required.

Tier 3 (preferred brand). Quantity limit of 2 per 30 days.

$203.24
Patient pays / month, after deductible
$732.14
Patient pays / month, before the $615.00 deductible
$609.73
Patient pays / 90 days by mail
$0
After the yearly $2,100.00 out-of-pocket cap

EMGALITY 120 mg/mL Injection, Solution at a preferred retail pharmacy, from the plan's negotiated price of $1,451.73 for a month. Other covered strengths are listed below.

Prior authRequired on all 3 covered forms· The plan decides within 72 hours, or 24 if expedited· If denied, the prescriber can ask the plan to reconsider (an appeal)
All 3 covered strengths and forms
FormTierPatient pays / monthLimits
EMGALITY 120 mg/mL Injection, Solution3$208.44PA · 2 per 30 days
EMGALITY 120 mg/mL Injection, Solution3$203.24PA · 2 per 30 days
EMGALITY 100 mg/mL Injection, Solution3$251.47PA · 3 per 30 days

Other CGRP migraine drugs on this plan

Verify with the plan before prescribing or filling. Member services: (888)285-2249. Data from the CMS 2026 Part D formulary and pricing files. Full plan details

Plan ID s5715-020